BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6331022)

  • 1. [Humoral response to Epstein-Barr virus of patients with nasopharyngeal cancer and its use in the differential diagnosis of the disease].
    Gurtsevich VE; Plakhov IV; Chuĭkina NA; Abdulin NA
    Vestn Akad Med Nauk SSSR; 1984; (5):29-34. PubMed ID: 6331022
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of the Epstein-Barr herpesvirus relationship with Hodgkin's disease and the use of virus immunological markers in differential diagnostics of nasopharyngeal carcinoma.
    Mazurenko NP; Gurtsevich VE; Stepina VN; Plakhov IV
    Arch Geschwulstforsch; 1983; 53(3):253-9. PubMed ID: 6311138
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rhinopharyngeal carcinoma and Epstein-Barr virus: study of a sample of Italian patients].
    Caliceti U; Cevenini R; Donati M
    Acta Otorhinolaryngol Ital; 1985; 5(1):83-90. PubMed ID: 2994355
    [No Abstract]   [Full Text] [Related]  

  • 4. Epstein-Barr virus specific antibodies in patients with IgA nephropathy.
    Wu AY; Lau YK; Chia KB; Lim CH
    Singapore Med J; 1988 Jun; 29(3):257-60. PubMed ID: 2847323
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-EBV antibody titers in Italian patients with nasopharyngeal carcinoma.
    Pirodda E; Caliceti U; Testoni S
    J Exp Pathol; 1987; 3(4):479-83. PubMed ID: 2842481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of Epstein-Barr virus-related diseases.
    Linde A
    Scand J Infect Dis Suppl; 1996; 100():83-8. PubMed ID: 8860358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The diagnostic value of Epstein-Barr virus diagnosis].
    Bauer G
    Internist (Berl); 1992 Sep; 33(9):586-92. PubMed ID: 1328107
    [No Abstract]   [Full Text] [Related]  

  • 8. Nasopharyngeal carcinoma due to Epstein-Barr virus: serologic tests.
    Smith TF
    Mayo Clin Proc; 1985 Mar; 60(3):205-6. PubMed ID: 2983152
    [No Abstract]   [Full Text] [Related]  

  • 9. [IgG and IgA antibodies to the Epstein-Barr virus and nasopharyngeal carcinoma].
    Vera Sempere FJ
    Med Clin (Barc); 1992 May; 98(19):758-9. PubMed ID: 1318986
    [No Abstract]   [Full Text] [Related]  

  • 10. Serological markers in the diagnosis of histopathological types of nasopharyngeal carcinoma.
    Sam CK; Prasad U; Pathmanathan R
    Eur J Surg Oncol; 1989 Aug; 15(4):357-60. PubMed ID: 2547665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT; Yeh CY
    Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus and nasopharyngeal cancer.
    Poole E; Stewart IA
    N Z Med J; 1984 Apr; 97(753):239. PubMed ID: 6326009
    [No Abstract]   [Full Text] [Related]  

  • 13. Early nasopharyngeal carcinoma among IgA/VCA antibody positive individuals detected by anticomplement immunoenzymatic method.
    Zeng Y; Shen SJ; Deng H; Ma JL; Zhang Q; Zhu JS; Cheng JR
    Chin Med J (Engl); 1984 Mar; 97(3):155-7. PubMed ID: 6088182
    [No Abstract]   [Full Text] [Related]  

  • 14. Presence of Epstein-Barr virus specific IgA in saliva of nasopharyngeal carcinoma patients: their activity, origin and possible clinical value.
    Desgranges C; de-The G
    IARC Sci Publ (1971); 1978; (20):459-69. PubMed ID: 215528
    [No Abstract]   [Full Text] [Related]  

  • 15. IgA and nasopharyngeal carcinoma.
    Desgranges C; De-The G
    IARC Sci Publ (1971); 1978; (24 Pt 2):883-91. PubMed ID: 221410
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relation between the growth pattern and the quantity of plasma cells of nasopharyngeal cancer (NPC) and serum EBV antibody level].
    Li JT
    Zhonghua Zhong Liu Za Zhi; 1985 Jan; 7(1):9-11. PubMed ID: 2983963
    [No Abstract]   [Full Text] [Related]  

  • 17. Epstein-Barr virus is not associated with head and neck neoplasms other than nasopharyngeal carcinoma.
    Kottaridis SD; Goula I; Kiparissiadis P
    Neoplasma; 1982; 29(3):327-31. PubMed ID: 6290911
    [No Abstract]   [Full Text] [Related]  

  • 18. Nasopharyngeal carcinoma: can antiviral interventions be contemplated to prevent this cancer?
    de-Thé G; Zeng Y
    Prog Clin Biol Res; 1983; 132B():37-47. PubMed ID: 6195669
    [No Abstract]   [Full Text] [Related]  

  • 19. The significance of serologic test for EB-virus antibody in occult type nasopharyngeal carcinoma.
    Furukawa M; Takimoto T; Morishita K; Komori T; Ishiguro H; Umeda R
    Auris Nasus Larynx; 1983; 10(1):43-8. PubMed ID: 6311149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of IgA serum antibodies to EB virus VCA in patients having survived nasopharyngeal cancer for over 15 years (author's transl)].
    Tang ZH
    Zhonghua Yi Xue Za Zhi; 1982 Mar; 62(3):167-9. PubMed ID: 6286059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.